胃肠道CAR T细胞淋巴瘤的长期随访:归巢、克隆扩增及对环孢素的反应
本研究基于单例病例探索胃肠道CAR T细胞相关淋巴瘤的发生机制,聚焦整合素α4β7表达和易感体细胞SH2B3突变的作用。观察到寡克隆CAR T细胞归巢至胃肠道并克隆扩增,优势克隆携带致病性SH2B3突变及CAR转基因整合于TFCP2位点,随后克隆性CAR T细胞进入外周血。临床、组织学和分子证据显示环孢素可减少扩增的恶性克隆并实现持续一年以上的临床缓解。
要点
- 单例病例中,胃肠道CAR T细胞淋巴瘤表现为寡克隆CAR T细胞归巢和克隆扩增。
- 优势扩增克隆携带致病性SH2B3突变及TFCP2位点的CAR转基因整合。
- 环孢素治疗可减少扩增的恶性克隆并实现持续一年以上的临床缓解。
核心结论
- CAR T细胞治疗、预先存在的遗传易感性和胃肠道微环境之间存在复杂相互作用,强调需要警惕监测和定制治疗策略以应对CAR T细胞淋巴瘤发生风险。
研究设计与样本
- 单例病例研究,探究胃肠道CAR T细胞相关淋巴瘤的发生机制。
主要发现
- 寡克隆CAR T细胞归巢至胃肠道并在其中克隆扩增。
- 优势扩增克隆携带致病性SH2B3突变和TFCP2位点的CAR转基因整合。
- 克隆性CAR T细胞随后从胃肠道进入外周血,提示潜在的全身播散途径。
- 临床、组织学和分子证据显示环孢素可减少扩增的恶性克隆并实现持续一年以上的临床缓解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative treatment for hematological malignancies, yet its potential to drive lymphomagenesis poses significant clinical concerns. In this study, we investigated the mechanisms underlying CAR T-cell-associated lymphomagenesis in the gastrointestinal (GI) tract on a single case, focusing specifically on the role of integrin α4β7 expression and a predisposing somatic SH2B3 mutation. We observed oligoclonal CAR T cells homing to, and clonally expanding in, the GI tract, with the dominant expanded clone harboring both a pathogenic SH2B3 mutation and a CAR transgene integration within a TFCP2 locus. The clonal CAR T cells subsequently transitioned beyond the GI tract into the peripheral blood, suggesting a potential pathway for systemic dissemination. We found clinical, histological, and molecular evidence demonstrating the efficacy of cyclosporine in reducing the expanded malignant clone and achieving durable clinical remission for more than a year. Our findings highlight the complex interplay between CAR T-cell therapy, preexisting genetic vulnerabilities, and the GI microenvironment, emphasizing the need for vigilant monitoring and tailored therapeutic strategies to address the risks associated with CAR T-cell lymphomagenesis.
引用
- Hosoya H, Bastidas Torres AN, Fernandez-Pol S, et al. Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine. Blood. 2026. PMID: 41288531. doi:10.1182/blood.2025031423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。